510(k) K212533
K212533 is an FDA 510(k) premarket notification submitted by Institut Straumann AG for the device "BLX WB Ø5.0 (L18), Ø5.5 and Ø6.5 mm (L14 and L16) Implants". The FDA issued a decision of Substantially Equivalent on Jan 28, 2022. The device falls under product code DZE (Implant, Endosseous, Root-Form), a Class II device regulated under 21 CFR 872.3640. Institut Straumann AG has 91 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 28, 2022
- Date Received
- Aug 11, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Implant, Endosseous, Root-Form
- Device Class
- Class II
- Regulation Number
- 872.3640
- Review Panel
- DE
- Submission Type
- 510(k)
Need the full FDA record for Institut Straumann AG? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.